Emerging and Practical Concepts and Controversies in Adult and AYA ALL
Aptitude Health organized this webinar on recent developments in the treatment of AYA and adult ALL patients that included information from ASH 2021, ASCO 2022, EHA 2022, EBMT 2022, as well as recent/upcoming peer-reviewed papers.
Experts shared their insights on enactment of new paradigms, including administration of new treatments such as bispecifics and patient monitoring and management. They also discussed strategic implementation of minimal residual disease (MRD) monitoring.
Date and Location
July 18 and September 6, 2022, Virtual Meeting
Nicola Gökbuget, MD
University Hospital Frankfurt, Germany
Nicolas Boissel, MD, PhD
Hôpital Saint-Louis, France
Local Chair: Shaun Fleming, MBBS(Hons), FRACP, FRCPA
Co-chairs: Nicola Gökbuget, MD, Nicolas Boissel, MD, PhD
|10 min||Welcome, Meeting Overview, and Introductions||Shaun Fleming, MBBS(Hons), FRACP, FRCPA|
|25 min||Overview of Key Takeaways in MRD and Its Role in Adult and AYA ALL Treatment||Nicola Gökbuget, MD|
|25 min||Overview of Key Takeaways in Recent Developments in AYA/Adult ALL||Nicolas Boissel, MD, PhD|
|75 min||Questions to Dr Boissel and Dr Gökbuget||Chun Yew Fong, MBBS, BMedSci, FRACP, FRCPA, PhD, and Matt Greenwood, MBBS, FRACP, FRCPA (panelists)|
|5 min||Conclusions and Wrap-up||Shaun Fleming, MBBS(Hons), FRACP, FRCPA|